Halozyme Therapeutics (HALO) Tops Q4 EPS by 3c; Guides FY15 Revs

Go back to Halozyme Therapeutics (HALO) Tops Q4 EPS by 3c; Guides FY15 Revs
Halozyme Therapeutics, Inc. (NASDAQ: HALO) Delayed: 111.75 +2.07 (1.89%)
Previous Close $109.68    52 Week High $18.39 
Open $109.72    52 Week Low $6.96 
Day High $112.45    P/E N/A 
Day Low $109.38    EPS $-0.58 
Volume 7,742,810